跳至主要内容
临床试验/CTRI/2019/12/022496
CTRI/2019/12/022496尚未招募2 期

Effect of MAGNESIUM GLYCINATE Supplementation in Type II Diabetic Patients

Dr Sakthi balan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male or female Type 2 DM patients treated with oral hypoglycemic agents, in the age group of 18-60 years.
  • 2.HbA1C levels of the patients should be between 6.5 to 7.0% in the last 3 months.
  • 3.Patients having low serum magnesium levels < 1.46 mg/dL21.
  • 4.Patient should have not participated in any other study during the past 3 months.

排除标准

  • 1.Patients who are having other conditions contraindicating for magnesium supplementation.
  • 2.Patients who are alcoholic, suffering from chronic diarrhoea and on treatment with diuretics within 4 weeks before study initiation.
  • 3.Pregnant and lactating women.
  • 4.Patients who are unable to sign informed consent or unable to comply with study procedure.

研究者

发起方
Dr Sakthi balan

相似试验

Magnesium in Diabetic Patients | 临床试验